Dianthus Therapeutics, Inc. announced the appointment of Jeffrey Stavenhagen, Ph.D., as Chief Scientific Officer. In this role, Dr. Stavenhagen will lead the Company?s discovery and preclinical research and translational science initiatives. Dr. Stavenhagen is a recognized expert in early-stage drug development, with more than 20 years of experience building and leading research teams to advance new therapeutic candidates into clinical development.

He was most recently Chief Scientific Officer at Therini Bio, where he directed R&D initiatives leading to the development of a first-in-class monoclonal antibody for the treatment of neurodegenerative diseases. He previously served in leadership roles at Therachon, leading preclinical research and CMC, and Lundbeck, advancing its first internal antibody programs into clinical development for neurodegenerative diseases. Dr. Stavenhagen began his biotech career as the first employee of MacroGenics, where he built a novel antibody engineering platform that resulted in Margenza®, one of the first Fc optimized monoclonal antibodies on the market.

Throughout his career, he has authored over 40 scientific patents and publications. Dr. Stavenhagen received his Ph.D. in Molecular Biology from Columbia University and performed post-doctoral studies at the Fred Hutchinson Research Center in Seattle. In addition, Dianthus announced that Jennifer Davis Ruff has joined the Company as Head of Investor Relations and Corporate Affairs.

She has more than 20 years of experience in investor relations and corporate communications in the biopharmaceutical and biotechnology industries. Ms. Ruff most recently served as Vice President, Investor Relations at Pyxis Oncology, where she led communications with investors and analysts. Previously, she held the roles of Vice President, Corporate Communications and Investor Relations at TESARO, Director, Investor Relations at Pfizer, and Director, Investor Relations and Corporate Communications at MGI Pharma. She earned a master?s degree in biotechnology from Northwestern University and a bachelor?s degree in biology from the University of Iowa.